University of Queensland's COVID vaccine technology finally moves to human trial phase after 2020 false start

Associate Professor Keith Chappell is leading UQ's Clamp2 project. (Supplied: University of Queensland )

A human trial has been launched into the University of Queensland's (UQ) second generation COVID vaccine, more than two years after the original technology was abandoned amid patients falsely testing positive to HIV.

UQ scientists have re-engineered the molecular clamp technology and need 70 healthy volunteers aged 18 to 50 to test its effectiveness as a COVID vaccine compared to the approved Novavax shot.